Form 4: Outset Medical Executive Sells Shares for Tax Obligations

Outset Medical's EVP of Operations, R&D & Service, Marc Nash, sold 1,817 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Marc Nash, EVP Operations R&D & Service at Outset Medical, Inc. (OM), reported a disposition of common stock.
• On February 17, 2026, Nash sold 1,817 shares of Outset Medical Common Stock at a price of $3.35 per share.
• This transaction was a 'sell to cover' to satisfy tax withholding obligations in connection with the vesting of an aggregate of 4,384 shares of Common Stock underlying Restricted Stock Units (RSUs).
• The RSUs were granted on March 15, 2021, July 24, 2023, January 12, 2024, and June 10, 2025.
• The sale was not a discretionary trade by the reporting person.
• Following this transaction, Marc Nash beneficially owns 39,988 shares of Outset Medical Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it's a non-discretionary sale for tax purposes, which is a standard practice for executive equity compensation and does not reflect a change in sentiment towards the company.

Positives

• The transaction is a routine compliance filing, indicating proper management of executive compensation and tax obligations.

Negatives

• The sale of shares by an executive, even for tax purposes, reduces their direct equity stake in the company.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing, as it is a report of a past insider transaction.

Management Comments

• This sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common practice for executives to manage tax liabilities upon the vesting of equity awards, and typically do not signal a change in management's outlook on the company's prospects, unlike discretionary sales.

Comparison to Industry Standards

• StockSavvy.ai observes that 'sell to cover' transactions are standard practice across industries for executives receiving equity compensation.
• Companies like Apple, Microsoft, and Google frequently see similar Form 4 filings from their executives when RSUs vest, as it's a tax-efficient method to cover statutory withholding requirements without requiring personal funds.
• This transaction aligns with typical executive compensation and tax management practices, indicating no deviation from industry norms.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a non-discretionary, tax-related sale, not indicative of a change in insider sentiment or company fundamentals.
• Employees: No direct impact from this specific transaction.

Key Dates

Keywords

Outset Medical, OM, Marc Nash, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Executive Compensation